25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

UBX (Unity Biotechnology Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Unity Biotechnology Inc together

I guess you are interested in Unity Biotechnology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Unity Biotechnology Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Unity Biotechnology Inc’s Price Targets

I'm going to help you getting a better view of Unity Biotechnology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Unity Biotechnology Inc

I send you an email if I find something interesting about Unity Biotechnology Inc.

1. Quick Overview

1.1. Quick analysis of Unity Biotechnology Inc (30 sec.)










1.2. What can you expect buying and holding a share of Unity Biotechnology Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
8.8%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-1.42
How sure are you?
20.6%

+ What do you gain per year?

Total Gains per Share
$-1.41
Return On Investment
-878.5%

For what price can you sell your share?

Current Price per Share
$0.16
Expected price per share
$0 - $1.13
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Unity Biotechnology Inc (5 min.)




Live pricePrice per Share (EOD)
$0.16
Intrinsic Value Per Share
$8.65 - $11.28
Total Value Per Share
$8.64 - $11.27

2.2. Growth of Unity Biotechnology Inc (5 min.)




Is Unity Biotechnology Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$205k$34.4m-$24.4m-243.4%

How much money is Unity Biotechnology Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.8m-$8.6m$1.8m26.5%
Net Profit Margin0.0%-76.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Unity Biotechnology Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#756 / 872

Most Revenue
#820 / 872

Most Profit
#473 / 872

Most Efficient
#262 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Unity Biotechnology Inc?

Welcome investor! Unity Biotechnology Inc's management wants to use your money to grow the business. In return you get a share of Unity Biotechnology Inc.

First you should know what it really means to hold a share of Unity Biotechnology Inc. And how you can make/lose money.

Speculation

The Price per Share of Unity Biotechnology Inc is $0.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Unity Biotechnology Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Unity Biotechnology Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $-0.35 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Unity Biotechnology Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-265.1%-0.40-249.7%-0.51-315.7%-0.55-345.5%-0.75-471.3%-0.89-556.7%
Usd Book Value Change Per Share-0.39-243.3%-0.35-219.6%-0.50-314.5%-0.25-154.0%-0.31-191.6%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.0958.7%
Usd Total Gains Per Share-0.39-243.3%-0.35-219.6%-0.50-314.5%-0.25-154.0%-0.31-191.6%0.0958.5%
Usd Price Per Share1.04-1.21-2.13-1.56-2.61-4.02-
Price to Earnings Ratio-0.61--0.80--2.08--1.11--1.07--1.15-
Price-to-Total Gains Ratio-2.67--3.72--4.64--3.46--3.29--3.96-
Price to Book Ratio-87.32--20.44-1.09--6.32--3.43--1.73-
Price-to-Total Gains Ratio-2.67--3.72--4.64--3.46--3.29--3.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.16
Number of shares6250
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.35-0.31
Usd Total Gains Per Share-0.35-0.31
Gains per Quarter (6250 shares)-2,196.21-1,916.05
Gains per Year (6250 shares)-8,784.83-7,664.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-8785-87950-7664-7674
20-17570-175800-15328-15338
30-26354-263650-22993-23002
40-35139-351500-30657-30666
50-43924-439350-38321-38330
60-52709-527200-45985-45994
70-61494-615050-53649-53658
80-70279-702900-61313-61322
90-79063-790750-68978-68986
100-87848-878600-76642-76650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.033.00.02.9%1.033.00.02.9%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.024.03.020.6%7.024.03.020.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.031.08.8%3.00.031.08.8%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.024.03.020.6%7.024.03.020.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Unity Biotechnology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.389-0.351-10%-0.503+29%-0.246-37%-0.307-21%0.000-100%
Book Value Per Share---0.0120.584-102%2.004-101%2.044-101%2.990-100%4.322-100%
Current Ratio--1.9473.019-36%4.987-61%4.267-54%5.354-64%7.335-73%
Debt To Asset Ratio--1.0070.791+27%0.537+87%0.606+66%0.555+81%0.424+137%
Debt To Equity Ratio---2.210-100%1.181-100%1.463-100%1.255-100%0.798-100%
Dividend Per Share----0%-0%-0%-0%0.094-100%
Enterprise Value--4281688.00014488271.020-70%35294736.000-88%33655329.750-87%61402443.850-93%130211882.250-97%
Eps---0.424-0.399-6%-0.505+19%-0.553+30%-0.754+78%-0.891+110%
Ev To Ebitda Ratio---0.159-0.581+265%-1.225+668%-0.950+496%-1.206+656%-1.943+1118%
Free Cash Flow Per Share---0.369-0.320-13%-0.450+22%-0.487+32%-0.624+69%-0.735+99%
Free Cash Flow To Equity Per Share---0.369-0.319-14%-0.627+70%-0.300-19%-0.279-24%0.021-1842%
Gross Profit Margin--1.1581.120+3%1.007+15%1.042+11%1.025+13%1.015+14%
Intrinsic Value_10Y_max--11.279----------
Intrinsic Value_10Y_min--8.650----------
Intrinsic Value_1Y_max---1.505----------
Intrinsic Value_1Y_min---1.480----------
Intrinsic Value_3Y_max---2.513----------
Intrinsic Value_3Y_min---2.440----------
Intrinsic Value_5Y_max---1.101----------
Intrinsic Value_5Y_min---1.194----------
Market Cap2753952.000-550%17900688.00020811271.020-14%36661986.000-51%26800829.750-33%44996993.850-60%69160138.324-74%
Net Profit Margin----0%-0.7610%-0.3440%-0.3180%-0.4590%
Operating Margin----0%-0.7610%0.077-100%-0.0570%-0.3120%
Operating Ratio----0%1.065-100%-0.0770%0.157-100%0.662-100%
Pb Ratio-13.434+85%-87.320-20.442-77%1.094-8082%-6.323-93%-3.433-96%-1.732-98%
Pe Ratio-0.094+85%-0.613-0.797+30%-2.084+240%-1.109+81%-1.069+74%-1.148+87%
Price Per Share0.160-550%1.0401.209-14%2.130-51%1.557-33%2.614-60%4.018-74%
Price To Free Cash Flow Ratio-0.108+85%-0.704-0.975+39%-1.224+74%-0.906+29%-1.042+48%-1.257+79%
Price To Total Gains Ratio-0.411+85%-2.672-3.717+39%-4.636+73%-3.465+30%-3.294+23%-3.960+48%
Quick Ratio--2.8694.882-41%6.749-57%6.617-57%8.649-67%11.098-74%
Return On Assets---0.241-0.175-27%-0.116-52%-0.136-44%-0.133-45%-0.134-44%
Return On Equity----0.5060%-0.2410%-0.3280%-0.2970%-0.2360%
Total Gains Per Share---0.389-0.351-10%-0.503+29%-0.246-37%-0.307-21%0.094-516%
Usd Book Value---205000.00010046750.000-102%34499750.000-101%35179833.333-101%51463250.000-100%74393323.529-100%
Usd Book Value Change Per Share---0.389-0.351-10%-0.503+29%-0.246-37%-0.307-21%0.000-100%
Usd Book Value Per Share---0.0120.584-102%2.004-101%2.044-101%2.990-100%4.322-100%
Usd Dividend Per Share----0%-0%-0%-0%0.094-100%
Usd Enterprise Value--4281688.00014488271.020-70%35294736.000-88%33655329.750-87%61402443.850-93%130211882.250-97%
Usd Eps---0.424-0.399-6%-0.505+19%-0.553+30%-0.754+78%-0.891+110%
Usd Free Cash Flow---6357000.000-5509750.000-13%-7741500.000+22%-8384500.000+32%-10735650.000+69%-12658911.765+99%
Usd Free Cash Flow Per Share---0.369-0.320-13%-0.450+22%-0.487+32%-0.624+69%-0.735+99%
Usd Free Cash Flow To Equity Per Share---0.369-0.319-14%-0.627+70%-0.300-19%-0.279-24%0.021-1842%
Usd Market Cap2753952.000-550%17900688.00020811271.020-14%36661986.000-51%26800829.750-33%44996993.850-60%69160138.324-74%
Usd Price Per Share0.160-550%1.0401.209-14%2.130-51%1.557-33%2.614-60%4.018-74%
Usd Profit---7302000.000-6875500.000-6%-8695500.000+19%-9702000.000+33%-13125900.000+80%-15417352.941+111%
Usd Revenue----0%475500.000-100%158500.000-100%334300.000-100%3340235.294-100%
Usd Total Gains Per Share---0.389-0.351-10%-0.503+29%-0.246-37%-0.307-21%0.094-516%
 EOD+2 -6MRQTTM+6 -26YOY+19 -153Y+12 -225Y+13 -2110Y+13 -23

3.3 Fundamental Score

Let's check the fundamental score of Unity Biotechnology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.094
Price to Book Ratio (EOD)Between0-1-13.434
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.869
Current Ratio (MRQ)Greater than11.947
Debt to Asset Ratio (MRQ)Less than11.007
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.241
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Unity Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5017.589
Ma 20Greater thanMa 500.620
Ma 50Greater thanMa 1000.747
Ma 100Greater thanMa 2001.085
OpenGreater thanClose0.150
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Unity Biotechnology Inc

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Its lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. The company also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, an a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2025-06-20 18:19:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Unity Biotechnology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Unity Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-76.1%+76.1%
TTM-5Y-31.8%+31.8%
5Y-31.8%10Y-45.9%+14.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--93.6%+93.6%
TTM--140.9%+140.9%
YOY-76.1%-197.6%+121.5%
3Y-34.4%-248.5%+214.1%
5Y-31.8%-343.4%+311.6%
10Y-45.9%-496.2%+450.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Unity Biotechnology Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • -24.1% Return on Assets means thatΒ Unity Biotechnology Inc generatedΒ $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Unity Biotechnology Inc:

  • The MRQ is -24.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-17.5%-6.5%
TTM-17.5%YOY-11.6%-6.0%
TTM-17.5%5Y-13.3%-4.3%
5Y-13.3%10Y-13.4%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%-11.6%-12.5%
TTM-17.5%-11.6%-5.9%
YOY-11.6%-11.4%-0.2%
3Y-13.6%-11.8%-1.8%
5Y-13.3%-12.0%-1.3%
10Y-13.4%-13.7%+0.3%
4.3.1.3. Return on Equity

Shows how efficient Unity Biotechnology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Unity Biotechnology Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Unity Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-50.6%+50.6%
TTM-50.6%YOY-24.1%-26.5%
TTM-50.6%5Y-29.7%-21.0%
5Y-29.7%10Y-23.6%-6.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM-50.6%-14.9%-35.7%
YOY-24.1%-14.6%-9.5%
3Y-32.8%-16.8%-16.0%
5Y-29.7%-17.5%-12.2%
10Y-23.6%-19.9%-3.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Unity Biotechnology Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Unity Biotechnology Inc is operatingΒ .

  • Measures how much profit Unity Biotechnology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Unity Biotechnology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-76.1%+76.1%
TTM-5Y-5.7%+5.7%
5Y-5.7%10Y-31.2%+25.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.5%+250.5%
YOY-76.1%-209.2%+133.1%
3Y7.7%-234.1%+241.8%
5Y-5.7%-346.1%+340.4%
10Y-31.2%-477.5%+446.3%
4.3.2.2. Operating Ratio

Measures how efficient Unity Biotechnology Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.065-1.065
TTM-5Y0.157-0.157
5Y0.15710Y0.662-0.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM-2.694-2.694
YOY1.0653.096-2.031
3Y-0.0773.652-3.729
5Y0.1574.745-4.588
10Y0.6626.614-5.952
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Unity Biotechnology Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.95Β means the company has $1.95 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 1.947. The company is able to pay all its short-term debts. +1
  • The TTM is 3.019. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.947TTM3.019-1.073
TTM3.019YOY4.987-1.968
TTM3.0195Y5.354-2.335
5Y5.35410Y7.335-1.980
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9473.661-1.714
TTM3.0193.846-0.827
YOY4.9874.140+0.847
3Y4.2674.688-0.421
5Y5.3545.746-0.392
10Y7.3356.147+1.188
4.4.3.2. Quick Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.87Β means the company can pay off $2.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 2.869. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.882. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.869TTM4.882-2.014
TTM4.882YOY6.749-1.867
TTM4.8825Y8.649-3.767
5Y8.64910Y11.098-2.449
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8692.848+0.021
TTM4.8823.169+1.713
YOY6.7493.786+2.963
3Y6.6174.311+2.306
5Y8.6495.703+2.946
10Y11.0986.368+4.730
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Unity Biotechnology Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Unity Biotechnology IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Unity Biotechnology Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.01Β means that Unity Biotechnology Inc assets areΒ financed with 100.7% credit (debt) and the remaining percentage (100% - 100.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 1.007. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.791. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.007TTM0.791+0.215
TTM0.791YOY0.537+0.254
TTM0.7915Y0.555+0.237
5Y0.55510Y0.424+0.130
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0070.329+0.678
TTM0.7910.349+0.442
YOY0.5370.331+0.206
3Y0.6060.340+0.266
5Y0.5550.349+0.206
10Y0.4240.379+0.045
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Unity Biotechnology Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.210-2.210
TTM2.210YOY1.181+1.029
TTM2.2105Y1.255+0.955
5Y1.25510Y0.798+0.457
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM2.2100.437+1.773
YOY1.1810.414+0.767
3Y1.4630.450+1.013
5Y1.2550.464+0.791
10Y0.7980.515+0.283
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Unity Biotechnology Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Unity Biotechnology Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.61 means the investor is paying $-0.61Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Unity Biotechnology Inc:

  • The EOD is -0.094. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.613. Based on the earnings, the company is expensive. -2
  • The TTM is -0.797. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.094MRQ-0.613+0.519
MRQ-0.613TTM-0.797+0.184
TTM-0.797YOY-2.084+1.288
TTM-0.7975Y-1.069+0.273
5Y-1.06910Y-1.148+0.079
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.094-2.356+2.262
MRQ-0.613-2.077+1.464
TTM-0.797-2.574+1.777
YOY-2.084-3.760+1.676
3Y-1.109-3.773+2.664
5Y-1.069-6.193+5.124
10Y-1.148-6.876+5.728
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Unity Biotechnology Inc:

  • The EOD is -0.108. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.704. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.975. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.108MRQ-0.704+0.596
MRQ-0.704TTM-0.975+0.271
TTM-0.975YOY-1.224+0.249
TTM-0.9755Y-1.042+0.067
5Y-1.04210Y-1.257+0.215
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.108-3.246+3.138
MRQ-0.704-2.705+2.001
TTM-0.975-3.704+2.729
YOY-1.224-4.402+3.178
3Y-0.906-5.070+4.164
5Y-1.042-8.477+7.435
10Y-1.257-9.305+8.048
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Unity Biotechnology Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -87.32 means the investor is paying $-87.32Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Unity Biotechnology Inc:

  • The EOD is -13.434. Based on the equity, the company is expensive. -2
  • The MRQ is -87.320. Based on the equity, the company is expensive. -2
  • The TTM is -20.442. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.434MRQ-87.320+73.887
MRQ-87.320TTM-20.442-66.879
TTM-20.442YOY1.094-21.536
TTM-20.4425Y-3.433-17.009
5Y-3.43310Y-1.732-1.701
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.4342.038-15.472
MRQ-87.3201.843-89.163
TTM-20.4422.125-22.567
YOY1.0942.442-1.348
3Y-6.3232.492-8.815
5Y-3.4333.652-7.085
10Y-1.7324.311-6.043
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Unity Biotechnology Inc.

4.8.1. Institutions holding Unity Biotechnology Inc

Institutions are holding 17.194% of the shares of Unity Biotechnology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31ARCH VENTURE CORP5.83780.5068100481700
2025-03-31Vanguard Group Inc3.910506730908232013.9344
2025-03-31Alyeska Investment Group, L.P.1.6970.0012292091-566992-65.9997
2025-03-31Financial Harvest, LLC1.19266.97512052702052700
2025-03-31Geode Capital Management, LLC0.9657016621368064.2696
2025-03-31Renaissance Technologies Corp0.54740.0002942111730022.4935
2025-03-31BlackRock Inc0.472908140200
2025-03-31Susquehanna International Group, LLP0.364506273644046235.6661
2025-03-31Bridgeway Capital Management, LLC0.29050.00135000000
2025-03-31Founders Fund V Management, LLC0.28574.77984917200
2025-03-31Morgan Stanley - Brokerage Accounts0.2519043356-36685-45.8328
2025-03-31Cercano Management LLC0.23960.00134123800
2025-03-31State Street Corp0.219803782400
2025-03-31Northern Trust Corp0.2060354521290357.222
2025-03-31SIMPLEX TRADING, LLC0.1796030908309080
2025-03-31Group One Trading, LP0.16630.000128625286250
2025-03-31Seacrest Wealth Management, LLC0.16150.003327800278000
2024-12-31Commonwealth Equity Services Inc0.14080242321200.4977
2025-03-31Virtu Financial LLC0.10480.00118046180460
2025-03-31Advisor Group Holdings, Inc.0.0729012554-74-0.586
Total 17.307812.27012979037-129607-4.4%

4.9.2. Funds holding Unity Biotechnology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.7789047830500
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.13170.000219478500
2025-04-30Fidelity Extended Market Index0.49330.000384905-811-0.9461
2025-03-31Bridgeway Ultra-Small Company Market0.29050.05315000000
2025-03-31Extended Equity Market Fund K0.21260.0003365891120.307
2025-04-30Fidelity Total Market Index0.160102755900
2025-03-31Northern Trust Extended Eq Market Idx0.13370.00032300912903127.6766
2025-03-31NT Ext Equity Mkt Idx Fd - L0.13370.00032300912903127.6766
2025-04-30Fidelity Series Total Market Index0.121802096400
2025-04-30Spartan Extended Market Index Pool F0.11130.0003191568114.4208
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.06670.00021148800
2025-04-30Spartan Total Market Index Pool G0.05610966100
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0520.00028943-163-1.79
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.03210.000355263118129.485
2025-03-31Extended Equity Market Fund M0.02660.00034583-156-3.2918
2025-04-30Fidelity Nasdaq Composite Index0.02250387000
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.0140.0001240824080
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.0140.0001240824080
2025-04-30DFA US Small Cap I0.01202062-4301-67.5939
2025-03-31Russell 2500 Alpha Tilts Fund T0.00990.0002170670.412
Total 5.87350.05621010936+29239+2.9%

5.3. Insider Transactions

Insiders are holding 1.903% of the shares of Unity Biotechnology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-27Alexander Hieu NguyenSELL19541.16
2025-02-04Alexander Hieu NguyenSELL1642.23
2025-02-04Anirvan GhoshSELL6422.23
2025-02-04Lynne Marie SullivanSELL1532.23
2024-08-02Alexander Hieu NguyenSELL1541.53
2024-08-02Anirvan GhoshSELL6041.53
2024-08-02Lynne Marie SullivanSELL1391.53
2024-06-25Alexander Hieu NguyenSELL781.4
2024-06-25Anirvan GhoshSELL12141.4
2024-06-25Lynne Marie SullivanSELL3241.4
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Stockholder Equity 23,988-4,23419,754-5,61014,144-7,6506,494-6,699-205
Net Invested Capital  23,988-4,23419,754-5,61014,144-7,6506,494-6,699-205
Total Other Income Expense Net 1,809-1091,700-1,5791211,4301,551-1,962-411



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets30,347
Total Liabilities30,552
Total Stockholder Equity-205
 As reported
Total Liabilities 30,552
Total Stockholder Equity+ -205
Total Assets = 30,347

Assets

Total Assets30,347
Total Current Assets17,647
Long-term Assets12,700
Total Current Assets
Cash And Cash Equivalents 7,999
Short-term Investments 8,934
Net Receivables 139
Other Current Assets 714
Total Current Assets  (as reported)17,647
Total Current Assets  (calculated)17,786
+/- 139
Long-term Assets
Property Plant Equipment 11,733
Long-term Assets Other 967
Long-term Assets  (as reported)12,700
Long-term Assets  (calculated)12,700
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,066
Long-term Liabilities21,486
Total Stockholder Equity-205
Total Current Liabilities
Short-term Debt 3,830
Accounts payable 1,761
Other Current Liabilities 7,305
Total Current Liabilities  (as reported)9,066
Total Current Liabilities  (calculated)12,896
+/- 3,830
Long-term Liabilities
Capital Lease Obligations 18,677
Long-term Liabilities  (as reported)21,486
Long-term Liabilities  (calculated)18,677
+/- 2,809
Total Stockholder Equity
Common Stock2
Retained Earnings -517,645
Accumulated Other Comprehensive Income 1
Other Stockholders Equity 517,437
Total Stockholder Equity (as reported)-205
Total Stockholder Equity (calculated)-205
+/-0
Other
Capital Stock2
Cash and Short Term Investments 16,933
Common Stock Shares Outstanding 16,871
Liabilities and Stockholders Equity 30,347
Net Debt 10,678
Net Invested Capital -205
Net Working Capital 8,581
Property Plant and Equipment Gross 11,733
Short Long Term Debt Total 18,677



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
96,648
0
0
0
102,024
144,102
208,456
194,721
181,375
160,797
154,210
141,678
151,221
157,787
164,698
174,971
156,319
148,185
136,263
125,691
124,712
112,469
97,593
136,393
124,350
114,255
101,008
69,270
65,690
58,863
53,522
47,132
37,662
30,347
30,34737,66247,13253,52258,86365,69069,270101,008114,255124,350136,39397,593112,469124,712125,691136,263148,185156,319174,971164,698157,787151,221141,678154,210160,797181,375194,721208,456144,102102,02400096,648
   > Total Current Assets 
93,409
89,286
0
0
88,880
136,439
187,621
179,816
172,965
151,840
141,427
125,873
129,487
115,233
123,537
135,690
100,866
102,041
87,608
84,726
90,504
81,483
67,822
102,724
96,535
86,381
72,966
49,538
46,605
38,519
35,846
30,263
24,267
17,647
17,64724,26730,26335,84638,51946,60549,53872,96686,38196,535102,72467,82281,48390,50484,72687,608102,041100,866135,690123,537115,233129,487125,873141,427151,840172,965179,816187,621136,43988,8800089,28693,409
       Cash And Cash Equivalents 
89,286
-89,286
0
0
7,298
62,754
34,165
28,897
15,399
34,249
23,113
36,768
37,473
25,059
39,592
48,581
17,807
26,842
13,498
21,994
32,905
16,446
19,442
22,576
12,736
22,972
19,118
7,876
19,803
7,430
7,584
8,898
7,580
7,999
7,9997,5808,8987,5847,43019,8037,87619,11822,97212,73622,57619,44216,44632,90521,99413,49826,84217,80748,58139,59225,05937,47336,76823,11334,24915,39928,89734,16562,7547,29800-89,28689,286
       Short-term Investments 
0
178,572
0
0
79,212
71,281
151,806
148,917
155,736
115,949
104,889
76,206
90,015
88,299
79,944
83,633
79,892
73,617
70,445
58,973
55,170
62,717
45,065
76,364
82,059
60,420
49,974
38,063
23,398
28,902
26,400
20,139
15,650
8,934
8,93415,65020,13926,40028,90223,39838,06349,97460,42082,05976,36445,06562,71755,17058,97370,44573,61779,89283,63379,94488,29990,01576,206104,889115,949155,736148,917151,80671,28179,21200178,5720
       Net Receivables 
0
0
0
0
1,382
0
0
0
0
0
10,650
10,650
0
0
0
0
0
0
0
0
0
0
0
0
235
1,500
1,743
1,711
0
1,614
0
0
139
139
139139001,61401,7111,7431,50023500000000000010,65010,650000001,3820000
       Other Current Assets 
4,123
0
0
0
988
2,404
3,300
4,004
3,660
3,284
2,775
2,249
1,999
1,875
4,001
6,952
6,334
3,164
7,330
3,759
2,429
2,320
3,315
3,784
2,828
2,989
2,131
1,888
871
573
1,862
1,226
898
714
7148981,2261,8625738711,8882,1312,9892,8283,7843,3152,3202,4293,7597,3303,1646,3346,9524,0011,8751,9992,2492,7753,2843,6604,0043,3002,4049880004,123
   > Long-term Assets 
0
-89,286
0
0
13,144
7,663
20,835
14,905
8,410
8,957
12,783
15,805
21,734
42,554
41,161
39,281
55,453
46,144
48,655
40,965
34,208
30,986
29,771
33,669
27,815
27,874
28,042
19,732
19,085
20,344
17,676
16,869
13,395
12,700
12,70013,39516,86917,67620,34419,08519,73228,04227,87427,81533,66929,77130,98634,20840,96548,65546,14455,45339,28141,16142,55421,73415,80512,7838,9578,41014,90520,8357,66313,14400-89,2860
       Property Plant Equipment 
2,248
0
0
0
6,958
6,591
6,595
6,345
6,238
5,880
5,658
5,359
16,636
40,510
39,117
37,833
36,136
34,908
33,667
32,464
31,228
30,014
28,813
27,717
26,867
26,053
25,242
18,836
18,063
17,292
16,530
15,773
12,356
11,733
11,73312,35615,77316,53017,29218,06318,83625,24226,05326,86727,71728,81330,01431,22832,46433,66734,90836,13637,83339,11740,51016,6365,3595,6585,8806,2386,3456,5956,5916,9580002,248
       Long Term Investments 
0
0
0
0
5,118
0
12,073
6,386
0
0
4,040
7,353
3,025
0
0
0
17,871
9,790
13,542
7,500
1,993
0
0
4,980
0
0
1,899
0
0
1,952
0
0
0
0
00001,952001,899004,980001,9937,50013,5429,79017,8710003,0257,3534,040006,38612,07305,1180000
       Long-term Assets Other 
0
-89,286
0
0
1,068
1,072
2,167
2,174
1,172
3,077
3,085
3,093
2,073
2,044
2,044
1,448
1,446
1,446
1,446
1,001
987
76
62
972
52
29
901
896
1,022
204
250
1,096
1,039
967
9671,0391,0962502041,022896901295297262769871,0011,4461,4461,4461,4482,0442,0442,0733,0933,0853,0771,1722,1742,1671,0721,06800-89,2860
> Total Liabilities 
7,095
0
0
0
11,181
242,733
13,387
15,205
20,682
14,194
27,160
26,961
30,514
52,458
52,439
76,870
73,439
68,232
70,346
67,954
65,143
61,778
57,662
57,828
57,502
55,627
51,601
33,064
37,292
34,875
33,768
32,988
31,168
30,552
30,55231,16832,98833,76834,87537,29233,06451,60155,62757,50257,82857,66261,77865,14367,95470,34668,23273,43976,87052,43952,45830,51426,96127,16014,19420,68215,20513,387242,73311,1810007,095
   > Total Current Liabilities 
3,691
0
0
0
7,897
10,663
9,405
11,690
16,582
11,111
15,232
14,318
17,216
14,569
15,669
16,925
14,463
10,269
13,395
12,977
16,617
17,905
16,419
16,774
19,620
21,579
22,222
8,633
7,840
7,732
8,818
8,784
9,260
9,066
9,0669,2608,7848,8187,7327,8408,63322,22221,57919,62016,77416,41917,90516,61712,97713,39510,26914,46316,92515,66914,56917,21614,31815,23211,11116,58211,6909,40510,6637,8970003,691
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,318
0
4,415
4,520
4,626
4,736
5,767
7,433
8,763
10,550
9,793
12,576
16,248
16,978
3,362
0
3,544
3,638
3,700
3,830
3,830
3,8303,8303,7003,6383,54403,36216,97816,24812,5769,79310,5508,7637,4335,7674,7364,6264,5204,41504,3180000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
945
3,055
4,837
7,087
6,776
9,476
12,783
13,704
0
0
0
0
0
0
0
000000013,70412,7839,4766,7767,0874,8373,0559450000000000000000000
       Accounts payable 
964
0
0
0
2,378
5,037
1,883
2,624
4,847
4,071
5,381
4,578
5,185
4,015
3,952
4,255
2,558
1,975
1,898
1,773
1,985
3,323
1,437
2,444
1,790
1,470
1,449
1,149
1,380
1,398
1,456
1,804
997
1,761
1,7619971,8041,4561,3981,3801,1491,4491,4701,7902,4441,4373,3231,9851,7731,8981,9752,5584,2553,9524,0155,1854,5785,3814,0714,8472,6241,8835,0372,378000964
       Other Current Liabilities 
2,727
0
0
0
5,519
5,626
7,522
9,066
11,735
7,040
9,851
9,740
12,031
6,236
11,717
8,255
7,385
3,668
6,761
5,437
6,983
5,603
4,432
4,537
5,254
4,140
3,795
4,122
10
2,790
3,724
6,980
4,433
7,305
7,3054,4336,9803,7242,790104,1223,7954,1405,2544,5374,4325,6036,9835,4376,7613,6687,3858,25511,7176,23612,0319,7409,8517,04011,7359,0667,5225,6265,5190002,727
   > Long-term Liabilities 
0
0
0
0
3,284
232,070
3,982
3,515
4,100
3,083
11,928
12,643
13,298
37,889
36,770
59,945
58,976
57,963
56,951
54,977
48,526
43,873
41,243
41,054
37,882
34,048
29,379
24,431
29,452
27,143
24,950
24,204
21,908
21,486
21,48621,90824,20424,95027,14329,45224,43129,37934,04837,88241,05441,24343,87348,52654,97756,95157,96358,97659,94536,77037,88913,29812,64311,9283,0834,1003,5153,982232,0703,2840000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,313
24,508
24,699
24,892
24,142
0
0
12,670
0
10,891
7,619
4,082
0
0
0
0
0
0
0
00000004,0827,61910,891012,6700024,14224,89224,69924,50824,313000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
33,571
36,770
31,217
34,468
28,638
27,300
25,045
27,039
20,576
18,023
17,999
17,515
9,902
8,319
21,069
26,990
19,062
18,021
16,998
19,709
14,847
14,84719,70916,99818,02119,06226,99021,0698,3199,90217,51517,99918,02320,57627,03925,04527,30028,63834,46831,21736,77033,5710000000000000
       Warrants
0
0
0
0
0
228,907
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000228,90700000
       Long-term Liabilities Other 
0
0
0
0
0
101
1,115
848
1,633
818
7
0
0
37,889
36,770
35,632
34,468
33,264
23
30,835
23
0
28,573
0
26,991
26,150
25,297
0
0
0
0
0
0
0
000000025,29726,15026,991028,57302330,8352333,26434,46835,63236,77037,8890078181,6338481,11510100000
       Deferred Long Term Liability 
0
0
0
0
0
3,062
2,867
2,667
2,467
2,265
11,921
12,643
13,298
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000013,29812,64311,9212,2652,4672,6672,8673,06200000
> Total Stockholder Equity
89,553
89,553
0
0
90,843
-98,631
195,069
179,516
160,693
146,603
127,050
114,717
120,707
105,329
112,259
98,101
82,880
79,953
65,917
57,737
59,569
50,691
39,931
78,565
66,848
58,628
49,407
36,206
28,398
23,988
19,754
14,144
6,494
-205
-2056,49414,14419,75423,98828,39836,20649,40758,62866,84878,56539,93150,69159,56957,73765,91779,95382,88098,101112,259105,329120,707114,717127,050146,603160,693179,516195,069-98,63190,8430089,55389,553
   Common Stock
1
0
0
0
3
1
4
4
4
4
4
4
5
5
5
5
5
5
5
5
6
7
7
1
1
1
1
1
0
2
2
2
2
2
2222201111177655555555444444130001
   Retained Earnings Total Equity0000000-483,021-470,816-459,9510-432,07600-389,331-372,881-355,055-339,299-319,712-292,160-273,493-245,455-227,428-205,718-182,045-163,278-141,362-123,015-103,01300000
   Accumulated Other Comprehensive Income 
0
-41,536
0
0
-104
-138
-77
-119
-95
19
113
95
90
373
232
66
5
15
5
6
-44
-176
-187
-275
-251
-150
-136
-55
0
-38
-35
39
15
1
11539-35-380-55-136-150-251-275-187-176-446515566232373909511319-95-119-77-138-10400-41,5360
   Capital Surplus 
0
0
0
0
0
5,511
318,758
321,594
324,663
329,226
333,252
342,647
366,695
379,072
404,754
417,952
422,379
435,198
438,788
447,057
0
0
472,187
0
527,049
529,593
532,563
0
0
0
0
0
0
0
0000000532,563529,593527,0490472,18700447,057438,788435,198422,379417,952404,754379,072366,695342,647333,252329,226324,663321,594318,7585,51100000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
-202
0
0
0
3,870
4,519
318,157
320,993
324,062
328,625
332,651
342,046
366,067
378,444
404,182
417,742
422,169
434,988
438,788
447,057
459,631
469,799
472,187
524,623
527,049
529,593
532,563
534,570
0
514,167
515,209
516,006
516,820
517,437
517,437516,820516,006515,209514,1670534,570532,563529,593527,049524,623472,187469,799459,631447,057438,788434,988422,169417,742404,182378,444366,067342,046332,651328,625324,062320,993318,1574,5193,870000-202



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-31,171
Operating Income-31,171-31,171
 
Operating Expense (+$)
Research Development13,006
Selling General Administrative15,460
Selling And Marketing Expenses0
Operating Expense31,17128,466
 
Net Interest Income (+$)
Interest Income1,733
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,733
 
Pretax Income (+$)
Operating Income-31,171
Net Interest Income1,733
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,990-36,352
EBIT - interestExpense = 0
-25,990
-25,990
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-25,990
Earnings Before Interest and Taxes (EBITDA)-25,123
 
After tax Income (+$)
Income Before Tax-25,990
Tax Provision-0
Net Income From Continuing Ops-25,990-25,990
Net Income-25,990
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net5,181-1,733
 

Technical Analysis of Unity Biotechnology Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Unity Biotechnology Inc. The general trend of Unity Biotechnology Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Unity Biotechnology Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Unity Biotechnology Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Unity Biotechnology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.66 < 0.9102 < 1.13.

The bearish price targets are: .

Know someone who trades $UBX? Share this with them.πŸ‘‡

Unity Biotechnology Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Unity Biotechnology Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Unity Biotechnology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Unity Biotechnology Inc. The current macd is -0.15572217.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Unity Biotechnology Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Unity Biotechnology Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Unity Biotechnology Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Unity Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) ChartUnity Biotechnology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Unity Biotechnology Inc. The current adx is 35.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Unity Biotechnology Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Unity Biotechnology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Unity Biotechnology Inc. The current sar is 0.93594593.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Unity Biotechnology Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Unity Biotechnology Inc. The current rsi is 17.59. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Unity Biotechnology Inc Daily Relative Strength Index (RSI) ChartUnity Biotechnology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Unity Biotechnology Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Unity Biotechnology Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Unity Biotechnology Inc Daily Stochastic Oscillator ChartUnity Biotechnology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Unity Biotechnology Inc. The current cci is -138.12974725.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Unity Biotechnology Inc Daily Commodity Channel Index (CCI) ChartUnity Biotechnology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Unity Biotechnology Inc. The current cmo is -76.38212236.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Unity Biotechnology Inc Daily Chande Momentum Oscillator (CMO) ChartUnity Biotechnology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Unity Biotechnology Inc. The current willr is -91.82692308.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Unity Biotechnology Inc Daily Williams %R ChartUnity Biotechnology Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Unity Biotechnology Inc.

Unity Biotechnology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Unity Biotechnology Inc. The current atr is 0.0963753.

Unity Biotechnology Inc Daily Average True Range (ATR) ChartUnity Biotechnology Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Unity Biotechnology Inc. The current obv is -22,090,803.

Unity Biotechnology Inc Daily On-Balance Volume (OBV) ChartUnity Biotechnology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Unity Biotechnology Inc. The current mfi is 2.53333015.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Unity Biotechnology Inc Daily Money Flow Index (MFI) ChartUnity Biotechnology Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Unity Biotechnology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Unity Biotechnology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Unity Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5017.589
Ma 20Greater thanMa 500.620
Ma 50Greater thanMa 1000.747
Ma 100Greater thanMa 2001.085
OpenGreater thanClose0.150
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Unity Biotechnology Inc with someone you think should read this too:
  • Are you bullish or bearish on Unity Biotechnology Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Unity Biotechnology Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Unity Biotechnology Inc

I send you an email if I find something interesting about Unity Biotechnology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Unity Biotechnology Inc.

Receive notifications about Unity Biotechnology Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.